nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—osteoarthritis—Prednisone—hematologic cancer	0.25	1	CpDpCtD
Nabumetone—MPO—hematologic cancer	0.222	1	CbGaD
Nabumetone—PTGS2—Lenalidomide—hematologic cancer	0.0412	0.126	CbGbCtD
Nabumetone—MPO—Cisplatin—hematologic cancer	0.0273	0.0831	CbGbCtD
Nabumetone—CYP1A2—Anagrelide—hematologic cancer	0.0224	0.0683	CbGbCtD
Nabumetone—PTGS2—Thalidomide—hematologic cancer	0.022	0.067	CbGbCtD
Nabumetone—PTGS1—Bortezomib—hematologic cancer	0.0213	0.065	CbGbCtD
Nabumetone—PTGS1—Thalidomide—hematologic cancer	0.0186	0.0566	CbGbCtD
Nabumetone—PTGS1—Ifosfamide—hematologic cancer	0.0164	0.0498	CbGbCtD
Nabumetone—PTGS1—Imatinib—hematologic cancer	0.0156	0.0476	CbGbCtD
Nabumetone—PTGS2—Triamcinolone—hematologic cancer	0.0153	0.0465	CbGbCtD
Nabumetone—PTGS2—Betamethasone—hematologic cancer	0.0131	0.0399	CbGbCtD
Nabumetone—CYP1A2—Carmustine—hematologic cancer	0.0118	0.0359	CbGbCtD
Nabumetone—CYP1A2—Methoxsalen—hematologic cancer	0.01	0.0305	CbGbCtD
Nabumetone—CYP1A2—Bortezomib—hematologic cancer	0.00953	0.029	CbGbCtD
Nabumetone—PTGS2—Cisplatin—hematologic cancer	0.00943	0.0287	CbGbCtD
Nabumetone—PTGS2—Etoposide—hematologic cancer	0.00926	0.0282	CbGbCtD
Nabumetone—CYP1A2—Daunorubicin—hematologic cancer	0.00912	0.0278	CbGbCtD
Nabumetone—CYP1A2—Alitretinoin—hematologic cancer	0.00893	0.0272	CbGbCtD
Nabumetone—CYP1A2—Thalidomide—hematologic cancer	0.00831	0.0253	CbGbCtD
Nabumetone—PTGS1—Etoposide—hematologic cancer	0.00782	0.0238	CbGbCtD
Nabumetone—PTGS2—Dexamethasone—hematologic cancer	0.00762	0.0232	CbGbCtD
Nabumetone—CYP1A2—Dacarbazine—hematologic cancer	0.00714	0.0217	CbGbCtD
Nabumetone—CYP1A2—Imatinib—hematologic cancer	0.00699	0.0213	CbGbCtD
Nabumetone—CYP1A2—Dasatinib—hematologic cancer	0.00561	0.0171	CbGbCtD
Nabumetone—PTGS2—ovarian follicle—hematologic cancer	0.00395	0.318	CbGeAlD
Nabumetone—CYP1A2—Etoposide—hematologic cancer	0.00349	0.0106	CbGbCtD
Nabumetone—Melatonin—CALR—hematologic cancer	0.0012	0.578	CrCbGaD
Nabumetone—MPO—hematopoietic system—hematologic cancer	0.00105	0.0846	CbGeAlD
Nabumetone—MPO—blood—hematologic cancer	0.000696	0.0561	CbGeAlD
Nabumetone—MPO—bone marrow—hematologic cancer	0.000673	0.0543	CbGeAlD
Nabumetone—MPO—lung—hematologic cancer	0.00061	0.0492	CbGeAlD
Nabumetone—MPO—testis—hematologic cancer	0.000576	0.0464	CbGeAlD
Nabumetone—CYP1A2—hematopoietic system—hematologic cancer	0.000575	0.0463	CbGeAlD
Nabumetone—PTGS1—hematopoietic system—hematologic cancer	0.000498	0.0401	CbGeAlD
Nabumetone—PTGS2—hematopoietic system—hematologic cancer	0.000476	0.0384	CbGeAlD
Nabumetone—MPO—lymph node—hematologic cancer	0.000417	0.0336	CbGeAlD
Nabumetone—CYP1A2—blood—hematologic cancer	0.000381	0.0307	CbGeAlD
Nabumetone—Naproxen—UGT1A1—hematologic cancer	0.000372	0.18	CrCbGaD
Nabumetone—CYP1A2—lung—hematologic cancer	0.000334	0.0269	CbGeAlD
Nabumetone—PTGS1—blood—hematologic cancer	0.00033	0.0266	CbGeAlD
Nabumetone—PTGS2—blood—hematologic cancer	0.000316	0.0254	CbGeAlD
Nabumetone—PTGS2—bone marrow—hematologic cancer	0.000305	0.0246	CbGeAlD
Nabumetone—PTGS1—lung—hematologic cancer	0.000289	0.0233	CbGeAlD
Nabumetone—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.00028	0.209	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.00028	0.209	CbGdCrCtD
Nabumetone—PTGS2—lung—hematologic cancer	0.000277	0.0223	CbGeAlD
Nabumetone—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	0.000274	0.205	CbGdCrCtD
Nabumetone—PTGS1—testis—hematologic cancer	0.000273	0.022	CbGeAlD
Nabumetone—Melatonin—MPO—hematologic cancer	0.000235	0.113	CrCbGaD
Nabumetone—PTGS1—lymph node—hematologic cancer	0.000198	0.0159	CbGeAlD
Nabumetone—PTGS2—lymph node—hematologic cancer	0.000189	0.0152	CbGeAlD
Nabumetone—Melatonin—ESR1—hematologic cancer	0.000176	0.0851	CrCbGaD
Nabumetone—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.000169	0.126	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	0.000169	0.126	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.000165	0.124	CbGdCrCtD
Nabumetone—Naproxen—ALB—hematologic cancer	9.11e-05	0.044	CrCbGaD
Nabumetone—Nausea—Ifosfamide—hematologic cancer	1.83e-05	0.000133	CcSEcCtD
Nabumetone—Feeling abnormal—Triamcinolone—hematologic cancer	1.82e-05	0.000132	CcSEcCtD
Nabumetone—Diarrhoea—Cisplatin—hematologic cancer	1.82e-05	0.000132	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—hematologic cancer	1.82e-05	0.000132	CcSEcCtD
Nabumetone—Anxiety—Prednisone—hematologic cancer	1.81e-05	0.000131	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—hematologic cancer	1.81e-05	0.000131	CcSEcCtD
Nabumetone—Vomiting—Gemcitabine—hematologic cancer	1.81e-05	0.000131	CcSEcCtD
Nabumetone—Insomnia—Betamethasone—hematologic cancer	1.81e-05	0.000131	CcSEcCtD
Nabumetone—Insomnia—Dexamethasone—hematologic cancer	1.81e-05	0.000131	CcSEcCtD
Nabumetone—Paraesthesia—Betamethasone—hematologic cancer	1.8e-05	0.00013	CcSEcCtD
Nabumetone—Paraesthesia—Dexamethasone—hematologic cancer	1.8e-05	0.00013	CcSEcCtD
Nabumetone—Discomfort—Prednisone—hematologic cancer	1.8e-05	0.00013	CcSEcCtD
Nabumetone—Rash—Gemcitabine—hematologic cancer	1.8e-05	0.00013	CcSEcCtD
Nabumetone—Dermatitis—Gemcitabine—hematologic cancer	1.8e-05	0.00013	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—hematologic cancer	1.79e-05	0.00013	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—hematologic cancer	1.79e-05	0.00013	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—hematologic cancer	1.79e-05	0.000129	CcSEcCtD
Nabumetone—Headache—Gemcitabine—hematologic cancer	1.79e-05	0.000129	CcSEcCtD
Nabumetone—Nausea—Vincristine—hematologic cancer	1.79e-05	0.000129	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—hematologic cancer	1.78e-05	0.000129	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisolone—hematologic cancer	1.77e-05	0.000128	CcSEcCtD
Nabumetone—Dyspepsia—Dexamethasone—hematologic cancer	1.76e-05	0.000128	CcSEcCtD
Nabumetone—Dyspepsia—Betamethasone—hematologic cancer	1.76e-05	0.000128	CcSEcCtD
Nabumetone—Urticaria—Triamcinolone—hematologic cancer	1.76e-05	0.000127	CcSEcCtD
Nabumetone—Asthenia—Etoposide—hematologic cancer	1.75e-05	0.000127	CcSEcCtD
Nabumetone—Body temperature increased—Triamcinolone—hematologic cancer	1.75e-05	0.000126	CcSEcCtD
Nabumetone—Oedema—Prednisone—hematologic cancer	1.75e-05	0.000126	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—hematologic cancer	1.75e-05	0.000126	CcSEcCtD
Nabumetone—Decreased appetite—Dexamethasone—hematologic cancer	1.74e-05	0.000126	CcSEcCtD
Nabumetone—Decreased appetite—Betamethasone—hematologic cancer	1.74e-05	0.000126	CcSEcCtD
Nabumetone—Nausea—Mitoxantrone—hematologic cancer	1.74e-05	0.000126	CcSEcCtD
Nabumetone—Nausea—Irinotecan—hematologic cancer	1.74e-05	0.000126	CcSEcCtD
Nabumetone—Fatigue—Betamethasone—hematologic cancer	1.73e-05	0.000125	CcSEcCtD
Nabumetone—Fatigue—Dexamethasone—hematologic cancer	1.73e-05	0.000125	CcSEcCtD
Nabumetone—Chills—Epirubicin—hematologic cancer	1.72e-05	0.000125	CcSEcCtD
Nabumetone—Pruritus—Etoposide—hematologic cancer	1.72e-05	0.000125	CcSEcCtD
Nabumetone—Shock—Prednisone—hematologic cancer	1.72e-05	0.000124	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—hematologic cancer	1.72e-05	0.000124	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—hematologic cancer	1.71e-05	0.000124	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—hematologic cancer	1.7e-05	0.000123	CcSEcCtD
Nabumetone—Nausea—Gemcitabine—hematologic cancer	1.69e-05	0.000123	CcSEcCtD
Nabumetone—Vomiting—Cisplatin—hematologic cancer	1.69e-05	0.000122	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisone—hematologic cancer	1.69e-05	0.000122	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—hematologic cancer	1.68e-05	0.000122	CcSEcCtD
Nabumetone—Rash—Cisplatin—hematologic cancer	1.68e-05	0.000121	CcSEcCtD
Nabumetone—Dermatitis—Cisplatin—hematologic cancer	1.67e-05	0.000121	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—hematologic cancer	1.67e-05	0.000121	CcSEcCtD
Nabumetone—Anorexia—Prednisone—hematologic cancer	1.66e-05	0.000121	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—hematologic cancer	1.66e-05	0.00012	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—hematologic cancer	1.66e-05	0.00012	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—hematologic cancer	1.65e-05	0.00012	CcSEcCtD
Nabumetone—Feeling abnormal—Betamethasone—hematologic cancer	1.65e-05	0.00012	CcSEcCtD
Nabumetone—Feeling abnormal—Dexamethasone—hematologic cancer	1.65e-05	0.00012	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—hematologic cancer	1.65e-05	0.000119	CcSEcCtD
Nabumetone—Tension—Epirubicin—hematologic cancer	1.64e-05	0.000119	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.64e-05	0.000119	CcSEcCtD
Nabumetone—Gastrointestinal pain—Betamethasone—hematologic cancer	1.64e-05	0.000119	CcSEcCtD
Nabumetone—Hypersensitivity—Triamcinolone—hematologic cancer	1.63e-05	0.000118	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—hematologic cancer	1.62e-05	0.000118	CcSEcCtD
Nabumetone—Malaise—Methotrexate—hematologic cancer	1.61e-05	0.000117	CcSEcCtD
Nabumetone—Dizziness—Etoposide—hematologic cancer	1.61e-05	0.000117	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—hematologic cancer	1.61e-05	0.000116	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—hematologic cancer	1.6e-05	0.000116	CcSEcCtD
Nabumetone—Chills—Doxorubicin—hematologic cancer	1.6e-05	0.000116	CcSEcCtD
Nabumetone—Urticaria—Dexamethasone—hematologic cancer	1.59e-05	0.000115	CcSEcCtD
Nabumetone—Urticaria—Betamethasone—hematologic cancer	1.59e-05	0.000115	CcSEcCtD
Nabumetone—Dizziness—Prednisolone—hematologic cancer	1.59e-05	0.000115	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—hematologic cancer	1.59e-05	0.000115	CcSEcCtD
Nabumetone—Asthenia—Triamcinolone—hematologic cancer	1.59e-05	0.000115	CcSEcCtD
Nabumetone—Body temperature increased—Dexamethasone—hematologic cancer	1.58e-05	0.000115	CcSEcCtD
Nabumetone—Body temperature increased—Betamethasone—hematologic cancer	1.58e-05	0.000115	CcSEcCtD
Nabumetone—Abdominal pain—Dexamethasone—hematologic cancer	1.58e-05	0.000115	CcSEcCtD
Nabumetone—Abdominal pain—Betamethasone—hematologic cancer	1.58e-05	0.000115	CcSEcCtD
Nabumetone—Nausea—Cisplatin—hematologic cancer	1.58e-05	0.000114	CcSEcCtD
Nabumetone—Insomnia—Prednisone—hematologic cancer	1.58e-05	0.000114	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—hematologic cancer	1.57e-05	0.000114	CcSEcCtD
Nabumetone—Paraesthesia—Prednisone—hematologic cancer	1.57e-05	0.000114	CcSEcCtD
Nabumetone—Pruritus—Triamcinolone—hematologic cancer	1.56e-05	0.000113	CcSEcCtD
Nabumetone—Cough—Methotrexate—hematologic cancer	1.56e-05	0.000113	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—hematologic cancer	1.55e-05	0.000112	CcSEcCtD
Nabumetone—Vomiting—Etoposide—hematologic cancer	1.55e-05	0.000112	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—hematologic cancer	1.55e-05	0.000112	CcSEcCtD
Nabumetone—Agitation—Epirubicin—hematologic cancer	1.54e-05	0.000111	CcSEcCtD
Nabumetone—Dyspepsia—Prednisone—hematologic cancer	1.54e-05	0.000111	CcSEcCtD
Nabumetone—Rash—Etoposide—hematologic cancer	1.54e-05	0.000111	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—hematologic cancer	1.53e-05	0.000111	CcSEcCtD
Nabumetone—Headache—Etoposide—hematologic cancer	1.53e-05	0.000111	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—hematologic cancer	1.53e-05	0.00011	CcSEcCtD
Nabumetone—Tension—Doxorubicin—hematologic cancer	1.52e-05	0.00011	CcSEcCtD
Nabumetone—Decreased appetite—Prednisone—hematologic cancer	1.52e-05	0.00011	CcSEcCtD
Nabumetone—Rash—Prednisolone—hematologic cancer	1.51e-05	0.00011	CcSEcCtD
Nabumetone—Dermatitis—Prednisolone—hematologic cancer	1.51e-05	0.00011	CcSEcCtD
Nabumetone—Malaise—Epirubicin—hematologic cancer	1.51e-05	0.000109	CcSEcCtD
Nabumetone—Fatigue—Prednisone—hematologic cancer	1.51e-05	0.000109	CcSEcCtD
Nabumetone—Headache—Prednisolone—hematologic cancer	1.51e-05	0.000109	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—hematologic cancer	1.5e-05	0.000109	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—hematologic cancer	1.5e-05	0.000109	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—hematologic cancer	1.5e-05	0.000109	CcSEcCtD
Nabumetone—Syncope—Epirubicin—hematologic cancer	1.5e-05	0.000109	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—hematologic cancer	1.5e-05	0.000108	CcSEcCtD
Nabumetone—Constipation—Prednisone—hematologic cancer	1.49e-05	0.000108	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—hematologic cancer	1.48e-05	0.000107	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—hematologic cancer	1.47e-05	0.000107	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—hematologic cancer	1.47e-05	0.000107	CcSEcCtD
Nabumetone—Dizziness—Triamcinolone—hematologic cancer	1.46e-05	0.000106	CcSEcCtD
Nabumetone—Cough—Epirubicin—hematologic cancer	1.46e-05	0.000106	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—hematologic cancer	1.46e-05	0.000106	CcSEcCtD
Nabumetone—Nausea—Etoposide—hematologic cancer	1.45e-05	0.000105	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—hematologic cancer	1.44e-05	0.000105	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisone—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Nabumetone—Asthenia—Dexamethasone—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Nabumetone—Asthenia—Betamethasone—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—hematologic cancer	1.44e-05	0.000104	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—hematologic cancer	1.43e-05	0.000104	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Nabumetone—Nausea—Prednisolone—hematologic cancer	1.43e-05	0.000103	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—hematologic cancer	1.42e-05	0.000103	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—hematologic cancer	1.42e-05	0.000103	CcSEcCtD
Nabumetone—Pruritus—Betamethasone—hematologic cancer	1.42e-05	0.000103	CcSEcCtD
Nabumetone—Pruritus—Dexamethasone—hematologic cancer	1.42e-05	0.000103	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—hematologic cancer	1.41e-05	0.000102	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—hematologic cancer	1.41e-05	0.000102	CcSEcCtD
Nabumetone—Vomiting—Triamcinolone—hematologic cancer	1.4e-05	0.000102	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—hematologic cancer	1.4e-05	0.000101	CcSEcCtD
Nabumetone—Rash—Triamcinolone—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Dermatitis—Triamcinolone—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—hematologic cancer	1.39e-05	0.000101	CcSEcCtD
Nabumetone—Urticaria—Prednisone—hematologic cancer	1.39e-05	0.0001	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—hematologic cancer	1.39e-05	0.0001	CcSEcCtD
Nabumetone—Headache—Triamcinolone—hematologic cancer	1.38e-05	0.0001	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—hematologic cancer	1.38e-05	0.0001	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—hematologic cancer	1.38e-05	0.0001	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—hematologic cancer	1.38e-05	9.97e-05	CcSEcCtD
Nabumetone—Diarrhoea—Dexamethasone—hematologic cancer	1.37e-05	9.93e-05	CcSEcCtD
Nabumetone—Diarrhoea—Betamethasone—hematologic cancer	1.37e-05	9.93e-05	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—hematologic cancer	1.37e-05	9.91e-05	CcSEcCtD
Nabumetone—Oedema—Epirubicin—hematologic cancer	1.37e-05	9.89e-05	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—hematologic cancer	1.37e-05	9.89e-05	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—hematologic cancer	1.36e-05	9.85e-05	CcSEcCtD
Nabumetone—Cough—Doxorubicin—hematologic cancer	1.35e-05	9.78e-05	CcSEcCtD
Nabumetone—Shock—Epirubicin—hematologic cancer	1.34e-05	9.73e-05	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—hematologic cancer	1.34e-05	9.68e-05	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—hematologic cancer	1.34e-05	9.68e-05	CcSEcCtD
Nabumetone—Dizziness—Dexamethasone—hematologic cancer	1.33e-05	9.6e-05	CcSEcCtD
Nabumetone—Dizziness—Betamethasone—hematologic cancer	1.33e-05	9.6e-05	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—hematologic cancer	1.32e-05	9.56e-05	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—hematologic cancer	1.32e-05	9.56e-05	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—hematologic cancer	1.31e-05	9.51e-05	CcSEcCtD
Nabumetone—Nausea—Triamcinolone—hematologic cancer	1.31e-05	9.5e-05	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—hematologic cancer	1.31e-05	9.49e-05	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—hematologic cancer	1.3e-05	9.43e-05	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—hematologic cancer	1.3e-05	9.43e-05	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—hematologic cancer	1.3e-05	9.42e-05	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—hematologic cancer	1.3e-05	9.39e-05	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—hematologic cancer	1.29e-05	9.34e-05	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisone—hematologic cancer	1.29e-05	9.32e-05	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—hematologic cancer	1.28e-05	9.3e-05	CcSEcCtD
Nabumetone—Vomiting—Dexamethasone—hematologic cancer	1.27e-05	9.23e-05	CcSEcCtD
Nabumetone—Vomiting—Betamethasone—hematologic cancer	1.27e-05	9.23e-05	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—hematologic cancer	1.27e-05	9.23e-05	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—hematologic cancer	1.27e-05	9.19e-05	CcSEcCtD
Nabumetone—Rash—Betamethasone—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Rash—Dexamethasone—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Dermatitis—Dexamethasone—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Dermatitis—Betamethasone—hematologic cancer	1.26e-05	9.15e-05	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—hematologic cancer	1.26e-05	9.11e-05	CcSEcCtD
Nabumetone—Headache—Betamethasone—hematologic cancer	1.26e-05	9.1e-05	CcSEcCtD
Nabumetone—Headache—Dexamethasone—hematologic cancer	1.26e-05	9.1e-05	CcSEcCtD
Nabumetone—Asthenia—Prednisone—hematologic cancer	1.25e-05	9.07e-05	CcSEcCtD
Nabumetone—Shock—Doxorubicin—hematologic cancer	1.24e-05	9e-05	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—hematologic cancer	1.24e-05	8.96e-05	CcSEcCtD
Nabumetone—Pruritus—Prednisone—hematologic cancer	1.24e-05	8.95e-05	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—hematologic cancer	1.23e-05	8.94e-05	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—hematologic cancer	1.23e-05	8.88e-05	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—hematologic cancer	1.22e-05	8.85e-05	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—hematologic cancer	1.22e-05	8.82e-05	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—hematologic cancer	1.21e-05	8.79e-05	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—hematologic cancer	1.2e-05	8.72e-05	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—hematologic cancer	1.2e-05	8.71e-05	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—hematologic cancer	1.2e-05	8.71e-05	CcSEcCtD
Nabumetone—Diarrhoea—Prednisone—hematologic cancer	1.19e-05	8.65e-05	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.19e-05	8.64e-05	CcSEcCtD
Nabumetone—Nausea—Betamethasone—hematologic cancer	1.19e-05	8.62e-05	CcSEcCtD
Nabumetone—Nausea—Dexamethasone—hematologic cancer	1.19e-05	8.62e-05	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—hematologic cancer	1.19e-05	8.6e-05	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—hematologic cancer	1.18e-05	8.53e-05	CcSEcCtD
Nabumetone—Constipation—Epirubicin—hematologic cancer	1.17e-05	8.46e-05	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—hematologic cancer	1.16e-05	8.39e-05	CcSEcCtD
Nabumetone—Dizziness—Prednisone—hematologic cancer	1.15e-05	8.36e-05	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—hematologic cancer	1.15e-05	8.35e-05	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—hematologic cancer	1.15e-05	8.35e-05	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—hematologic cancer	1.14e-05	8.28e-05	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—hematologic cancer	1.13e-05	8.22e-05	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—hematologic cancer	1.13e-05	8.16e-05	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—hematologic cancer	1.13e-05	8.15e-05	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—hematologic cancer	1.12e-05	8.13e-05	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.12e-05	8.09e-05	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—hematologic cancer	1.11e-05	8.05e-05	CcSEcCtD
Nabumetone—Vomiting—Prednisone—hematologic cancer	1.11e-05	8.04e-05	CcSEcCtD
Nabumetone—Rash—Prednisone—hematologic cancer	1.1e-05	7.97e-05	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—hematologic cancer	1.1e-05	7.97e-05	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—hematologic cancer	1.1e-05	7.95e-05	CcSEcCtD
Nabumetone—Headache—Prednisone—hematologic cancer	1.09e-05	7.92e-05	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—hematologic cancer	1.09e-05	7.89e-05	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—hematologic cancer	1.08e-05	7.86e-05	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—hematologic cancer	1.08e-05	7.82e-05	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—hematologic cancer	1.08e-05	7.82e-05	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—hematologic cancer	1.08e-05	7.82e-05	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—hematologic cancer	1.07e-05	7.79e-05	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—hematologic cancer	1.05e-05	7.58e-05	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—hematologic cancer	1.04e-05	7.54e-05	CcSEcCtD
Nabumetone—Nausea—Prednisone—hematologic cancer	1.04e-05	7.51e-05	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.03e-05	7.48e-05	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—hematologic cancer	1.03e-05	7.48e-05	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—hematologic cancer	1.01e-05	7.29e-05	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—hematologic cancer	1e-05	7.27e-05	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—hematologic cancer	9.99e-06	7.23e-05	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—hematologic cancer	9.99e-06	7.23e-05	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—hematologic cancer	9.98e-06	7.23e-05	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—hematologic cancer	9.8e-06	7.1e-05	CcSEcCtD
Nabumetone—PTGS2—Metabolism—HMMR—hematologic cancer	9.76e-06	0.000213	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AGO2—hematologic cancer	9.7e-06	0.000211	CbGpPWpGaD
Nabumetone—Pruritus—Epirubicin—hematologic cancer	9.66e-06	7e-05	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—hematologic cancer	9.65e-06	6.99e-05	CcSEcCtD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.65e-06	0.00021	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HDAC9—hematologic cancer	9.6e-06	0.000209	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—SLC22A1—hematologic cancer	9.56e-06	0.000208	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CRABP1—hematologic cancer	9.56e-06	0.000208	CbGpPWpGaD
Nabumetone—PTGS2—Disease—H3F3B—hematologic cancer	9.5e-06	0.000207	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.4e-06	0.000205	CbGpPWpGaD
Nabumetone—Diarrhoea—Epirubicin—hematologic cancer	9.34e-06	6.77e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism—ALOX5—hematologic cancer	9.32e-06	0.000203	CbGpPWpGaD
Nabumetone—Hypersensitivity—Doxorubicin—hematologic cancer	9.31e-06	6.74e-05	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—hematologic cancer	9.28e-06	6.72e-05	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	9.26e-06	0.000202	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.21e-06	0.000201	CbGpPWpGaD
Nabumetone—Rash—Methotrexate—hematologic cancer	9.2e-06	6.66e-05	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—hematologic cancer	9.19e-06	6.66e-05	CcSEcCtD
Nabumetone—PTGS2—Metabolism—ARNTL—hematologic cancer	9.18e-06	0.0002	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NPM1—hematologic cancer	9.15e-06	0.000199	CbGpPWpGaD
Nabumetone—Headache—Methotrexate—hematologic cancer	9.14e-06	6.62e-05	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—hematologic cancer	9.06e-06	6.57e-05	CcSEcCtD
Nabumetone—CYP1A2—Metabolism—B3GAT1—hematologic cancer	9.04e-06	0.000197	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ASNS—hematologic cancer	9.04e-06	0.000197	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—DCK—hematologic cancer	9.04e-06	0.000197	CbGpPWpGaD
Nabumetone—Dizziness—Epirubicin—hematologic cancer	9.03e-06	6.54e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism—NUP98—hematologic cancer	9.03e-06	0.000197	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	9.01e-06	0.000196	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	8.99e-06	0.000196	CbGpPWpGaD
Nabumetone—Pruritus—Doxorubicin—hematologic cancer	8.94e-06	6.47e-05	CcSEcCtD
Nabumetone—PTGS2—Metabolism—CA9—hematologic cancer	8.93e-06	0.000195	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ACP5—hematologic cancer	8.93e-06	0.000195	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.84e-06	0.000193	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOR2—hematologic cancer	8.81e-06	0.000192	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADCY7—hematologic cancer	8.76e-06	0.000191	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOA3—hematologic cancer	8.76e-06	0.000191	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF19—hematologic cancer	8.76e-06	0.000191	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NUP214—hematologic cancer	8.7e-06	0.00019	CbGpPWpGaD
Nabumetone—PTGS2—Disease—RPS14—hematologic cancer	8.69e-06	0.000189	CbGpPWpGaD
Nabumetone—Vomiting—Epirubicin—hematologic cancer	8.68e-06	6.29e-05	CcSEcCtD
Nabumetone—Nausea—Methotrexate—hematologic cancer	8.67e-06	6.28e-05	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—hematologic cancer	8.64e-06	6.26e-05	CcSEcCtD
Nabumetone—PTGS2—Disease—DKK1—hematologic cancer	8.62e-06	0.000188	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.61e-06	0.000188	CbGpPWpGaD
Nabumetone—Rash—Epirubicin—hematologic cancer	8.61e-06	6.24e-05	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—hematologic cancer	8.6e-06	6.23e-05	CcSEcCtD
Nabumetone—CYP1A2—Metabolism—HDC—hematologic cancer	8.57e-06	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT5B—hematologic cancer	8.56e-06	0.000187	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NUP98—hematologic cancer	8.56e-06	0.000187	CbGpPWpGaD
Nabumetone—Headache—Epirubicin—hematologic cancer	8.55e-06	6.2e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism—ABCG2—hematologic cancer	8.52e-06	0.000186	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTR—hematologic cancer	8.52e-06	0.000186	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—IDH1—hematologic cancer	8.39e-06	0.000183	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	8.39e-06	0.000183	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CST3—hematologic cancer	8.37e-06	0.000182	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ENO2—hematologic cancer	8.36e-06	0.000182	CbGpPWpGaD
Nabumetone—Dizziness—Doxorubicin—hematologic cancer	8.35e-06	6.05e-05	CcSEcCtD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	8.32e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ADCY7—hematologic cancer	8.31e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTO1—hematologic cancer	8.3e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCC3—hematologic cancer	8.3e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—TXN—hematologic cancer	8.3e-06	0.000181	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NUP214—hematologic cancer	8.25e-06	0.00018	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SPHK1—hematologic cancer	8.12e-06	0.000177	CbGpPWpGaD
Nabumetone—Nausea—Epirubicin—hematologic cancer	8.11e-06	5.87e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism—GSTT1—hematologic cancer	8.11e-06	0.000177	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTR—hematologic cancer	8.08e-06	0.000176	CbGpPWpGaD
Nabumetone—PTGS2—Disease—XIAP—hematologic cancer	8.08e-06	0.000176	CbGpPWpGaD
Nabumetone—Vomiting—Doxorubicin—hematologic cancer	8.03e-06	5.82e-05	CcSEcCtD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.99e-06	0.000174	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.98e-06	0.000174	CbGpPWpGaD
Nabumetone—Rash—Doxorubicin—hematologic cancer	7.97e-06	5.77e-05	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—hematologic cancer	7.96e-06	5.76e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism—SDC1—hematologic cancer	7.92e-06	0.000173	CbGpPWpGaD
Nabumetone—PTGS2—Disease—ENO2—hematologic cancer	7.92e-06	0.000173	CbGpPWpGaD
Nabumetone—Headache—Doxorubicin—hematologic cancer	7.91e-06	5.73e-05	CcSEcCtD
Nabumetone—PTGS2—Disease—SMARCA4—hematologic cancer	7.87e-06	0.000172	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CDA—hematologic cancer	7.84e-06	0.000171	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—UGT1A1—hematologic cancer	7.8e-06	0.00017	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	7.65e-06	0.000167	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SLC22A1—hematologic cancer	7.59e-06	0.000166	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CRABP1—hematologic cancer	7.59e-06	0.000166	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.57e-06	0.000165	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PC—hematologic cancer	7.55e-06	0.000165	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SDC1—hematologic cancer	7.51e-06	0.000164	CbGpPWpGaD
Nabumetone—Nausea—Doxorubicin—hematologic cancer	7.5e-06	5.44e-05	CcSEcCtD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.47e-06	0.000163	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALOX5—hematologic cancer	7.4e-06	0.000161	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	7.4e-06	0.000161	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC35B2—hematologic cancer	7.29e-06	0.000159	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GBA—hematologic cancer	7.29e-06	0.000159	CbGpPWpGaD
Nabumetone—PTGS2—Disease—LCK—hematologic cancer	7.27e-06	0.000159	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NUP98—hematologic cancer	7.17e-06	0.000156	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.15e-06	0.000156	CbGpPWpGaD
Nabumetone—PTGS2—Disease—H3F3A—hematologic cancer	7.13e-06	0.000155	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADCY7—hematologic cancer	6.96e-06	0.000152	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOA3—hematologic cancer	6.96e-06	0.000152	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCZ—hematologic cancer	6.93e-06	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NUP214—hematologic cancer	6.91e-06	0.000151	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.84e-06	0.000149	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CALR—hematologic cancer	6.81e-06	0.000148	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTR—hematologic cancer	6.77e-06	0.000148	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCG2—hematologic cancer	6.77e-06	0.000148	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NQO1—hematologic cancer	6.74e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CD44—hematologic cancer	6.74e-06	0.000147	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PARP1—hematologic cancer	6.69e-06	0.000146	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTAP—hematologic cancer	6.67e-06	0.000145	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ENO2—hematologic cancer	6.64e-06	0.000145	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.6e-06	0.000144	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FBXW7—hematologic cancer	6.59e-06	0.000144	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HDAC2—hematologic cancer	6.46e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CXCR4—hematologic cancer	6.46e-06	0.000141	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTT1—hematologic cancer	6.44e-06	0.00014	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD44—hematologic cancer	6.39e-06	0.000139	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CYCS—hematologic cancer	6.38e-06	0.000139	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.34e-06	0.000138	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—HSP90AA1—hematologic cancer	6.33e-06	0.000138	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CBL—hematologic cancer	6.29e-06	0.000137	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—SDC1—hematologic cancer	6.29e-06	0.000137	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	6.25e-06	0.000136	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.01e-06	0.000131	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HSP90AA1—hematologic cancer	6e-06	0.000131	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—FHL2—hematologic cancer	5.94e-06	0.00013	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.93e-06	0.000129	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AGRN—hematologic cancer	5.83e-06	0.000127	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT1—hematologic cancer	5.79e-06	0.000126	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.7e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.67e-06	0.000124	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTP1—hematologic cancer	5.62e-06	0.000123	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HMMR—hematologic cancer	5.52e-06	0.00012	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—IDH2—hematologic cancer	5.52e-06	0.00012	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.44e-06	0.000119	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GRB2—hematologic cancer	5.42e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFA—hematologic cancer	5.4e-06	0.000118	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NQO1—hematologic cancer	5.35e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CD44—hematologic cancer	5.35e-06	0.000117	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KITLG—hematologic cancer	5.33e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ABCB1—hematologic cancer	5.32e-06	0.000116	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.24e-06	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.21e-06	0.000114	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT5A—hematologic cancer	5.21e-06	0.000114	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ARNTL—hematologic cancer	5.19e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GSTM1—hematologic cancer	5.16e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—NCOR1—hematologic cancer	5.16e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN2B—hematologic cancer	5.16e-06	0.000113	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CYCS—hematologic cancer	5.06e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ACP5—hematologic cancer	5.05e-06	0.00011	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CA9—hematologic cancer	5.05e-06	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—HSP90AA1—hematologic cancer	5.03e-06	0.00011	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD86—hematologic cancer	4.99e-06	0.000109	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.99e-06	0.000109	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HES1—hematologic cancer	4.92e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NCOR1—hematologic cancer	4.9e-06	0.000107	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF1—hematologic cancer	4.84e-06	0.000106	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FOXO1—hematologic cancer	4.77e-06	0.000104	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFRB—hematologic cancer	4.76e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—IDH1—hematologic cancer	4.75e-06	0.000104	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.7e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.7e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—TXN—hematologic cancer	4.7e-06	0.000102	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFRA—hematologic cancer	4.69e-06	0.000102	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAK1—hematologic cancer	4.67e-06	0.000102	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PRKCG—hematologic cancer	4.67e-06	0.000102	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.6e-06	0.0001	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—MTHFR—hematologic cancer	4.56e-06	9.95e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.53e-06	9.87e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTP1—hematologic cancer	4.46e-06	9.73e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.42e-06	9.63e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTHFR—hematologic cancer	4.33e-06	9.43e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.32e-06	9.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TERT—hematologic cancer	4.31e-06	9.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HLA-A—hematologic cancer	4.31e-06	9.41e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CRABP1—hematologic cancer	4.3e-06	9.37e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SLC22A1—hematologic cancer	4.3e-06	9.37e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ABCB1—hematologic cancer	4.22e-06	9.21e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PDGFB—hematologic cancer	4.21e-06	9.18e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALOX5—hematologic cancer	4.19e-06	9.13e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TSC2—hematologic cancer	4.12e-06	8.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—NCOR1—hematologic cancer	4.1e-06	8.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GSTM1—hematologic cancer	4.1e-06	8.94e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NUP98—hematologic cancer	4.05e-06	8.84e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.02e-06	8.77e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGFR3—hematologic cancer	3.96e-06	8.63e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.94e-06	8.58e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.94e-06	8.58e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NUP214—hematologic cancer	3.91e-06	8.52e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.87e-06	8.43e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CG—hematologic cancer	3.83e-06	8.36e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.83e-06	8.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTR—hematologic cancer	3.83e-06	8.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ENO2—hematologic cancer	3.76e-06	8.19e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BAD—hematologic cancer	3.75e-06	8.18e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NOTCH1—hematologic cancer	3.72e-06	8.1e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.64e-06	7.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD80—hematologic cancer	3.64e-06	7.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KIT—hematologic cancer	3.63e-06	7.92e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—MTHFR—hematologic cancer	3.62e-06	7.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.59e-06	7.82e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PTPN11—hematologic cancer	3.57e-06	7.79e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—SDC1—hematologic cancer	3.56e-06	7.76e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—CREBBP—hematologic cancer	3.56e-06	7.75e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CREB1—hematologic cancer	3.46e-06	7.54e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—BRAF—hematologic cancer	3.42e-06	7.45e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.4e-06	7.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6R—hematologic cancer	3.38e-06	7.36e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.37e-06	7.35e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CREBBP—hematologic cancer	3.37e-06	7.35e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.36e-06	7.32e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ALB—hematologic cancer	3.33e-06	7.25e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAP2K1—hematologic cancer	3.22e-06	7.01e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.21e-06	7e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CD—hematologic cancer	3.2e-06	6.97e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.19e-06	6.96e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.18e-06	6.94e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—FGF2—hematologic cancer	3.06e-06	6.67e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CG—hematologic cancer	3.04e-06	6.64e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NQO1—hematologic cancer	3.03e-06	6.6e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CD44—hematologic cancer	3.03e-06	6.6e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3R1—hematologic cancer	3.02e-06	6.58e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.96e-06	6.46e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CB—hematologic cancer	2.94e-06	6.41e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—JAK2—hematologic cancer	2.93e-06	6.39e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CYCS—hematologic cancer	2.86e-06	6.24e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MDM2—hematologic cancer	2.86e-06	6.24e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.85e-06	6.2e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—CREBBP—hematologic cancer	2.82e-06	6.15e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CB—hematologic cancer	2.79e-06	6.07e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MTOR—hematologic cancer	2.79e-06	6.07e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—hematologic cancer	2.78e-06	6.06e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CD—hematologic cancer	2.68e-06	5.83e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ALB—hematologic cancer	2.64e-06	5.76e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1B—hematologic cancer	2.61e-06	5.7e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.56e-06	5.58e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PTEN—hematologic cancer	2.54e-06	5.54e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3R1—hematologic cancer	2.53e-06	5.51e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.52e-06	5.5e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.44e-06	5.32e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—EP300—hematologic cancer	2.42e-06	5.28e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CDKN1A—hematologic cancer	2.41e-06	5.26e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PTEN—hematologic cancer	2.41e-06	5.25e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.39e-06	5.21e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CB—hematologic cancer	2.33e-06	5.09e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.32e-06	5.06e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.32e-06	5.06e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—EP300—hematologic cancer	2.3e-06	5e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SRC—hematologic cancer	2.23e-06	4.87e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—STAT3—hematologic cancer	2.15e-06	4.69e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—NRAS—hematologic cancer	2.15e-06	4.68e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MAPK3—hematologic cancer	2.06e-06	4.48e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.05e-06	4.47e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PTEN—hematologic cancer	2.02e-06	4.39e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—MYC—hematologic cancer	2e-06	4.36e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—TGFB1—hematologic cancer	2e-06	4.35e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—EP300—hematologic cancer	1.92e-06	4.19e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—KRAS—hematologic cancer	1.85e-06	4.03e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.81e-06	3.94e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.79e-06	3.9e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.72e-06	3.76e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—PIK3CA—hematologic cancer	1.7e-06	3.7e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.6e-06	3.48e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—HRAS—hematologic cancer	1.57e-06	3.42e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.51e-06	3.3e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—hematologic cancer	1.5e-06	3.28e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ALB—hematologic cancer	1.49e-06	3.26e-05	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—AKT1—hematologic cancer	1.46e-06	3.19e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.43e-06	3.12e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PIK3CA—hematologic cancer	1.42e-06	3.1e-05	CbGpPWpGaD
Nabumetone—PTGS2—Disease—AKT1—hematologic cancer	1.39e-06	3.02e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.32e-06	2.88e-05	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—AKT1—hematologic cancer	1.16e-06	2.53e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PTEN—hematologic cancer	1.14e-06	2.49e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—EP300—hematologic cancer	1.09e-06	2.37e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	8.05e-07	1.75e-05	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—AKT1—hematologic cancer	6.57e-07	1.43e-05	CbGpPWpGaD
